Pilot Study Evaluating Panitumumab-IRDye800 as an Optical Imaging Agent to Detect Intracranial Lesions During Neurosurgical Procedures
Conditions
- Meningioma
- Glioblastoma
- Acoustic Neuroma
- Brain Cancer
- Pituitary Adenoma
Interventions
- DRUG: Panitumumab-IRDye800
Sponsor
Eben Rosenthal